Drug interactions in prescriptions for patients with conditional anticoagulation in two specialized outpatient clinics
DOI:
https://doi.org/10.33448/rsd-v13i5.45680Keywords:
Warfarin; Drug interactions; Atrial fibrillation; Anticoagulants; Ambulatory care.Abstract
Objective: to identify medication prescriptions for elderly patients undergoing anticoagulant treatment and potential interactions with warfarin. Methodology: Descriptive study, with patients with atrial fibrillation, over 18 years of age, treated at the anticoagulation outpatient clinics of two hospitals in Belo Horizonte, between June and December 2018, using warfarin for at least six months. Patients at these outpatient clinics were approached to identify medication prescriptions made by primary care doctors. The variables were analyzed: medications used and potential drug interactions with warfarin, observing the frequencies through the database created in an Excel spreadsheet. Results: at Hospital 1, 127 patients were evaluated, with a median age of 66 years, the majority of whom were men (50.4%). The most commonly used medications were: simvastatin (21.3%), spironolactone (14.6%) and omeprazole (11.9%). Of the total number of patients, 106 use medications that can interact with warfarin. At Hospital 2, 105 patients were evaluated, with a median age of 65 years, the majority of whom were women (67.6%). The most prescribed medications were: simvastatin (19.6%), omeprazole (15.8%) and acetylsalicylic acid (14.2%). At this institution, 99 patients used medications that could interact with warfarin. Conclusion: there is a high frequency of prescription of medications that interact with warfarin in the populations studied, reinforcing the need for therapeutic monitoring.
References
Ageno, W. et al. (2012). Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 141(2). https://journal.chestnet.org/article/S0012-3692(12)60119-6/fulltext.
Aldactone, CaroSpir (spironolactone) dosing, indications, interactions, adverse effects, and more. (n.d.). Reference.medscape.com. https://reference.medscape.com/drug/carospir-aldactone-spironolactone-342407#0
Andersson, M. L., Mannheimer, B., & Lindh, J. (2019). The effect of simvastatin on warfarin anticoagulation: a Swedish register-based nationwide cohort study. European Journal of Clinical Pharmacology, 75(10), 1387-1392.
Bajorek, B. et al. (2016). Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation : a cross-sectional baseline analysis in general practice. Journal of Clinical Pharmacy and Therapeutics, 41(4), 432–440.
BM Micromedex® Drug Interaction Checking: (n.d.). https://www. micromedexsolutions.com/home/dispatch/ssl/true.
Estrutura Física – EBSERH. (n.d.). http://www2.ebserh.gov.br/web/hc-ufmg/infraestrutura
Gage, B. F. et al. (2019). Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty. JAMA - Journal of the American Medical Association. 322(9):834–842
Guyatt, G. H. et al. (2012). Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines, 141(2), 27-47.
January, C. T. et al. (2014). AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 64 (21).
Jeddy A. S., & Gleason B. L. (2003). Aspirin and warfarin versus aspirin monotherapy after myocardial infarction. Ann Pharmacother., 37(10), 1502-1505.
Justo, F. A., & Silva A. F. G. (2014). Aspectos epidemiológicos da fibrilação. Revista de Medicina, 93(1), 1–13.
Maher, J. R., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 57–65.
Maryellen, M. S. et al. (2017) Identificação De Interações Medicamentosas E Eventos Hemorrágicos Em Idosos Em Uso De Varfarina. Revista de Atenção primária à saúde, 20(4): 592-601.
Merchán-Hamann, E., & Tauil, P. L. (2021). Proposta de classificação dos diferentes tipos de estudos epidemiológicos descritivos. Epidemiologia E Serviços de Saúde, 30(1). https://doi.org/10.1590/s1679-49742021000100026
Nasse, S., Mullan, J., & Beata, B. (2011) Challenges of Older Patients’ Knowledge About Warfarin Therapy. Journal of Primary Care & Community Health, 3(1), 65-74.
O'reilly, R. A. (1980). Spironolactone and warfarin interaction. Clinical Pharmacological Therapy, 27(2), 198-201.
Paradella, R. (2018). Número de idosos cresce 18% em 5 anos e ultrapassa 30 milhões em 2017. (n.d.). https://agenciadenoticias.ibge.gov.br/agencia-noticias/2012-agencia-de-noticias/noticias/20980-numero-de-idosos-cresce-18-em-5-anos-e-ultrapassa-30-milhoes-em-2017.
Prilosec (omeprazole) dosing, indications, interactions, adverse effects, and more. (n.d.). Reference.medscape.com. https://reference.medscape.com/drug/prilosec-omeprazole-341997#0
Ridge, A. et al. (2019). Assessing risk of adverse drug reactions in the elderly: a feasibility study. International Journal of Clinical Pharmacy, (n.d.)
Rose, A. J. et al. (2015). Comparison of the Abilities of Summary Measures of International Normalized Ratio Control to Predict Clinically Relevant Bleeding. Circ Cardiovasc Qual Outcomes, 8, 524-531.
Sociedade Brasileira de Arritmias Cardíacas. (2002). Sobrac.Org.https://sobrac.org/campanha/home-campanha/
Sutfin, T. et al. (1989). Stereoselective Interaction of Omeprazole with Warfarin in Healthy Men. Therapeutic Drug Monitoring. 11(2), 176–184.
Tadesse, S. F. et al. (2018) Assessment of Antibiotic Utilization Pattern in Treatment of Acute Diarrhoea Diseases in Bishoftu General Hospital, Oromia Ethiopia. Revista Hindawi. https://www.hindawi.com/journals/amed/2018/2376825/.
Teklay, G. et al. (2014). Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study. Thrombosis Journal. 20(12):1-8.
Theme, F. M. M. et al. (2015). Prevalência de doenças crônicas não transmissíveis e associação com autoavaliação de saúde: Pesquisa Nacional de Saúde. Revista Brasileira de Epidemiologia. 18(2):83-96.
Zocor, FloLipid (simvastatin) dosing, indications, interactions, adverse effects, and more. (n.d.). Reference.medscape.com. https://reference.medscape.com/drug/zocor-simvastatin-342463#0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gabrielle de Matos Maranha; Lais Almeida Figueiredo; Julia Satler Gonçalves Silva; Camila Emanuele Moreira Fernandes; Caryne Margotto Bertollo; Josiane Moreira da Costa; Maria Auxiliadora Parreiras Martins
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
